Florian H. Heidel, Mithun V. Shah, Robert L. Redner, Amitava Mitra, Harris S. Soifer, Marilyn Tabachri, Zijing Zhang, Marcie Riches, Daniel Corum, Mollie Leoni, Lionel Adès, Jessica K. Altman, Maria R. Baer, Suresh Balasubramanian, Frederic Barabé, Julie Bergeron, Teresa Bernal del Castillo, Céline Berthon, Adolfo De La Fuente Burguera, Dries Deeren, Mahmoud Elsawy, Harry Erba, Jordi Esteve Reyner, Amir T. Fathi, Kateryna Fedorov, James Foran, Caterina Giannini, Maël Heiblig, Florian Heidel, Ghayas C. Issa, Mohamad Khawandanah, Francesco Lanza, Yazan F. Madanat, James McCloskey, Pau Montesinos, Cristina Papayannidis, Agustin Penedo, Pierre Peterlin, Kristen Pettit, Arnaud Pigneux, Robert Redner, Gail J. Roboz, Eduardo Rodríguez-Arbolí, Olga Salamero Garcia, Adrian Schwarzer, Mithun Shah, Matthew Ulrickson, Adriano Venditti, Roland B. Walter, Eunice S. Wang. "Ziftomenib in Relapsed or Refractory NPM1 -Mutated AML." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-25-01694